Free Trial

Tourmaline Bio (TRML) News Today

Tourmaline Bio logo
$15.27 +0.16 (+1.06%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$16.75 +1.48 (+9.69%)
As of 05/22/2025 05:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TRML Latest News

Tourmaline Bio, Inc. stock logo
Wexford Capital LP Purchases New Position in Tourmaline Bio, Inc. (NASDAQ:TRML)
Wexford Capital LP acquired a new position in Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 20,610 shares of the company's stock, valued at approxim
Tourmaline Bio, Inc. stock logo
Tourmaline Bio, Inc. (NASDAQ:TRML) Stake Increased by Velan Capital Investment Management LP
Velan Capital Investment Management LP raised its position in shares of Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) by 28.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 423,795 shares of the company's stock after pur
Tourmaline Bio, Inc. stock logo
Analysts Set Expectations for Tourmaline Bio FY2025 Earnings
Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) - Stock analysts at Chardan Capital upped their FY2025 earnings estimates for shares of Tourmaline Bio in a research report issued to clients and investors on Monday, May 5th. Chardan Capital analyst D. Gataulin now forecasts that the company will
Tourmaline Bio, Inc. stock logo
Leerink Partnrs Comments on Tourmaline Bio FY2025 Earnings
Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) - Leerink Partnrs lowered their FY2025 earnings per share estimates for shares of Tourmaline Bio in a research report issued on Monday, May 5th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings per share of ($3.71)
Tourmaline Bio, Inc. stock logo
Brokers Set Expectations for Tourmaline Bio FY2025 Earnings
Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) - Research analysts at Cantor Fitzgerald lifted their FY2025 earnings estimates for Tourmaline Bio in a research report issued on Sunday, May 4th. Cantor Fitzgerald analyst J. Schimmer now forecasts that the company will post earnings of ($3.15) pe
Tourmaline Bio, Inc. stock logo
Q2 EPS Estimates for Tourmaline Bio Decreased by Analyst
Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) - Stock analysts at HC Wainwright lowered their Q2 2025 EPS estimates for shares of Tourmaline Bio in a report issued on Monday, May 5th. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings per share of ($0.91) for the
Tourmaline Bio, Inc. stock logo
Leerink Partnrs Weighs in on Tourmaline Bio Q2 Earnings
Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) - Research analysts at Leerink Partnrs issued their Q2 2025 earnings estimates for Tourmaline Bio in a research note issued to investors on Monday, May 5th. Leerink Partnrs analyst T. Smith forecasts that the company will post earnings per share of
Tourmaline Bio, Inc. stock logo
Alyeska Investment Group L.P. Lowers Position in Tourmaline Bio, Inc. (NASDAQ:TRML)
Alyeska Investment Group L.P. decreased its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) by 39.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 115,053 shares of the company's stock
Tourmaline Bio, Inc. stock logo
HC Wainwright Weighs in on Tourmaline Bio Q2 Earnings
Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) - Equities research analysts at HC Wainwright issued their Q2 2026 earnings per share estimates for shares of Tourmaline Bio in a research note issued on Monday, May 5th. HC Wainwright analyst Y. Chen forecasts that the company will post earnings o
Tourmaline Bio, Inc. stock logo
Tourmaline Bio (NASDAQ:TRML) Receives "Buy" Rating from HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $50.00 target price on shares of Tourmaline Bio in a report on Monday.
Tourmaline Bio, Inc. stock logo
Tourmaline Bio's (TRML) "Buy" Rating Reiterated at Chardan Capital
Chardan Capital reissued a "buy" rating and set a $70.00 target price on shares of Tourmaline Bio in a research report on Monday.
Tourmaline Bio, Inc. stock logo
Tourmaline Bio (TRML) Expected to Announce Earnings on Monday
Tourmaline Bio (NASDAQ:TRML) will be releasing its Q1 2025 earnings before the market opens on Monday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-12-tourmaline-bio-inc-stock/)
Tourmaline Bio, Inc. stock logo
Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Purchased by Barclays PLC
Barclays PLC raised its holdings in Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) by 84.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 58,566 shares of the company's stock after acquiring an additional 26,733 shares d
Tourmaline Bio, Inc. stock logo
Susquehanna Fundamental Investments LLC Invests $467,000 in Tourmaline Bio, Inc. (NASDAQ:TRML)
Susquehanna Fundamental Investments LLC bought a new stake in Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 23,044 shares of the company's stock, v
Tourmaline Bio, Inc. stock logo
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Average Rating of "Buy" from Brokerages
Tourmaline Bio, Inc. (NASDAQ:TRML - Get Free Report) has been given a consensus recommendation of "Buy" by the seven research firms that are covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12 month price objective among brokera
Tourmaline Bio, Inc. stock logo
Tourmaline Bio (NASDAQ:TRML) Issues Earnings Results
Tourmaline Bio (NASDAQ:TRML - Get Free Report) released its quarterly earnings results on Friday. The company reported ($0.89) EPS for the quarter, topping the consensus estimate of ($0.91) by $0.02.
Tourmaline Bio, Inc. stock logo
Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Purchased by Acuta Capital Partners LLC
Acuta Capital Partners LLC boosted its holdings in Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) by 5.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 351,842 shares of the company's stock after buying an additio
Tourmaline Bio, Inc. stock logo
Schonfeld Strategic Advisors LLC Acquires 100,139 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML)
Schonfeld Strategic Advisors LLC grew its holdings in shares of Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) by 50.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 298,239 shares of the company's stock af
Tourmaline Bio, Inc. stock logo
Nantahala Capital Management LLC Lowers Stock Position in Tourmaline Bio, Inc. (NASDAQ:TRML)
Nantahala Capital Management LLC trimmed its holdings in shares of Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) by 23.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 536,944 shares of the compan
Tourmaline Bio, Inc. stock logo
Adage Capital Partners GP L.L.C. Takes Position in Tourmaline Bio, Inc. (NASDAQ:TRML)
Adage Capital Partners GP L.L.C. bought a new stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 600,000 shares of the company's stock, valued
Tourmaline Bio, Inc. stock logo
Tourmaline Bio, Inc. (NASDAQ:TRML) Position Trimmed by Marshall Wace LLP
Marshall Wace LLP cut its stake in Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) by 16.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 116,091 shares of the company's stock after selling 22,103 shares during the qu
Tourmaline Bio, Inc. stock logo
Chardan Capital Weighs in on Tourmaline Bio FY2025 Earnings
Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) - Research analysts at Chardan Capital issued their FY2025 earnings estimates for shares of Tourmaline Bio in a research report issued on Wednesday, April 23rd. Chardan Capital analyst D. Gataulin anticipates that the company will post earnings of
Tourmaline Bio, Inc. stock logo
Blue Owl Capital Holdings LP Sells 451,080 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML)
Blue Owl Capital Holdings LP trimmed its holdings in shares of Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) by 29.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,079,321 shares of the company's
Tourmaline Bio, Inc. stock logo
Tourmaline Bio (NASDAQ:TRML) Coverage Initiated at Chardan Capital
Chardan Capital assumed coverage on shares of Tourmaline Bio in a research report on Wednesday. They issued a "buy" rating and a $70.00 price target for the company.
Tourmaline Bio initiated with a Buy at Chardan
Tourmaline Bio (TRML) Gets a Buy from Chardan Capital
Tourmaline Bio, Inc. stock logo
Nan Fung Group Holdings Ltd Acquires 40,290 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML)
Nan Fung Group Holdings Ltd grew its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) by 27.4% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 187,090 shares of the company's stock after purchasing an additional 40,290 sh
Tourmaline Bio, Inc. stock logo
Vanguard Group Inc. Boosts Stock Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML)
Vanguard Group Inc. grew its position in Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) by 4.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,106,125 shares of the company's stock after purchasin
Tourmaline Bio, Inc. stock logo
American Century Companies Inc. Purchases New Stake in Tourmaline Bio, Inc. (NASDAQ:TRML)
American Century Companies Inc. acquired a new position in Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 23,357 shares of the company's stock, valued
Tourmaline Bio, Inc. stock logo
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Rating of "Buy" by Brokerages
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML - Get Free Report) have been given a consensus rating of "Buy" by the six research firms that are currently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 1 year target pr
Tourmaline Bio price target lowered to $63 from $74 at Truist
Tourmaline Bio, Inc. stock logo
Polymer Capital Management HK LTD Acquires Shares of 79,400 Tourmaline Bio, Inc. (NASDAQ:TRML)
Polymer Capital Management HK LTD purchased a new stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 79,400 shares of the company's st
Tourmaline Bio, Inc. stock logo
Pictet Asset Management Holding SA Boosts Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML)
Pictet Asset Management Holding SA increased its holdings in shares of Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) by 69.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 419,883 shares of the company
Truist biotech analyst holds an analyst/industry conference call
Tourmaline Bio, Inc. stock logo
Swiss National Bank Takes Position in Tourmaline Bio, Inc. (NASDAQ:TRML)
Swiss National Bank bought a new position in shares of Tourmaline Bio, Inc. (NASDAQ:TRML - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 20,100 shares of the company's stock, valued at approximately $4
Tourmaline Bio, Inc. stock logo
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Recommendation of "Buy" by Analysts
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML - Get Free Report) have been assigned a consensus rating of "Buy" from the eight research firms that are presently covering the firm, Marketbeat.com reports. Eight investment analysts have rated the stock with a buy recommendation. The average 1 year pri
Tourmaline Bio, Inc. stock logo
Tourmaline Bio (NASDAQ:TRML) Given New $43.00 Price Target at Wedbush
Wedbush upped their target price on shares of Tourmaline Bio from $42.00 to $43.00 and gave the company an "outperform" rating in a research note on Friday.
Tourmaline Bio (TRML) Gets a Buy from Wedbush
Tourmaline Bio, Inc. stock logo
Tourmaline Bio (NASDAQ:TRML) Stock Price Expected to Rise, HC Wainwright Analyst Says
HC Wainwright increased their price target on shares of Tourmaline Bio from $49.00 to $50.00 and gave the company a "buy" rating in a research report on Friday.
Get Tourmaline Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRML and its competitors with MarketBeat's FREE daily newsletter.

TRML Media Mentions By Week

TRML Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TRML
News Sentiment

0.72

0.69

Average
Medical
News Sentiment

TRML News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TRML Articles
This Week

6

3

TRML Articles
Average Week

Get Tourmaline Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRML and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TRML) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners